Maria Chiara De Santis

Learn More
In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003(More)
LBA4519 Background: About 50% of pts with advanced UC are not eligible for cisplatin based CHT ("unfit") due to impaired renal function, performance status (PS) or comorbidity. This is the first(More)